JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB278777

Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7]

Be the first to review this product! Submit a review

|

(6 Publications)

Rabbit Recombinant Monoclonal NF-kB p65 phospho S536 antibody. Suitable for Flow Cyt, WB and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Synthetic Peptide within Human RELA pS536.

View Alternative Names

NFKB3, RELA, Transcription factor p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3

2 Images
Flow Cytometry - Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7] (AB278777)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7] (AB278777)

Flow cytometric analysis of HeLa cells unstained and untreated as negative control (blue) or stained and untreated (red) or stained and treated with TNFa plus CalA (green) using ab278777 at 0.05 ug/mL.

Western blot - Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7] (AB278777)
  • WB

Supplier Data

Western blot - Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7] (AB278777)

All lanes:

Western blot - Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7] (ab278777) at 0.05 µg/mL

Lane 1:

HeLa cell extract treated with TNFa plus CAlA

Lane 2:

HeLa cell extract untreated

Predicted band size: 60 kDa

false

  • 660 APC

    APC Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7]

  • 519 FITC

    FITC Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7]

  • 578 PE

    PE Anti-NF-kB p65 (phospho S536) antibody [NFKBp65S536-B7]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

NFKBp65S536-B7

Isotype

IgG

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

Flow Cyt, WB

applications

Immunogen

Synthetic Peptide within Human RELA pS536. The exact immunogen used to generate this antibody is proprietary information.

Q04206

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "0.001-1 µg/mL", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.05 µg/mL", "WB-species-notes": "<p></p>" } } }

Product details

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A/G
Storage buffer
Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NF-kB p65 also known as RelA is a significant component of the NF-kB protein complex. This complex usually involves a molecular weight for p65 of approximately 65 kDa. NF-kB p65 is mechanistically a transcription factor that regulates genes involved in inflammation cell survival and immune response. Expression of p65 is widely seen in various cell types including immune cells and epithelial cells suggesting its role in numerous physiological processes.
Biological function summary

NF-kB p65 acts as part of the larger NF-kB complex usually forming a heterodimer with other family members like p50. This complex translocates to the nucleus upon activation where it binds specific DNA sequences to regulate gene expression. The p65 subunit is essential for transactivating target genes involved in immune and inflammatory responses. Its regulation is important for proper cellular functioning especially in the maintenance of immune homeostasis and inflammatory response.

Pathways

NF-kB p65 participates in critical pathways like the NF-kB signaling and Toll-like receptor pathways. These pathways are fundamental for initiating immune responses and contribute to the regulation of apoptosis and cellular stress responses. In the context of these pathways the IKK complex plays a pivotal role in NF-kB activation leading to the phosphorylation and subsequent degradation of inhibitors that retain NF-kB p65 in the cytoplasm therefore allowing its movement to the nucleus.

NF-kB p65 is implicated in conditions such as cancer and autoimmune diseases. Its dysregulation can lead to persistent activation of inflammatory pathways contributing to tumorigenesis and chronic inflammation. In the context of these diseases proteins such as the p50 subunit and the IKK complex are often involved reflecting the importance of tight regulation of NF-kB signaling in preventing pathological conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric RELA-NFKB1 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. The NF-kappa-B heterodimeric RELA-NFKB1 and RELA-REL complexes, for instance, function as transcriptional activators. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The inhibitory effect of I-kappa-B on NF-kappa-B through retention in the cytoplasm is exerted primarily through the interaction with RELA. RELA shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Besides its activity as a direct transcriptional activator, it is also able to modulate promoters accessibility to transcription factors and thereby indirectly regulate gene expression. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1. Essential for cytokine gene expression in T-cells (PubMed : 15790681). The NF-kappa-B homodimeric RELA-RELA complex appears to be involved in invasin-mediated activation of IL-8 expression. Key transcription factor regulating the IFN response during SARS-CoV-2 infection (PubMed : 33440148).
See full target information RELA pS536

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Journal of cellular and molecular medicine 29:e70421 PubMed39972942

2025

LncRNA FAM30A Suppresses Proliferation and Metastasis of Colorectal Carcinoma by Blocking the JAK-STAT Signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Jin Liu,Shuangyin Han,Yuanbo Cui,Qiuyan Zhao,Yunfei Wang,Tian Li,Xiuling Li

Molecular neurobiology 62:4008-4022 PubMed39370481

2024

Hypoxia-Induced Inflammation in In Vitro Model of Human Blood-Brain Barrier: Modulatory Effects of the Olfactory Ensheathing Cell-Conditioned Medium.

Applications

Unspecified application

Species

Unspecified reactive species

Aleksandra Agafonova,Alessia Cosentino,Nicolò Musso,Chiara Prinzi,Cristina Russo,Rosalia Pellitteri,Carmelina Daniela Anfuso,Gabriella Lupo

Open medicine (Warsaw, Poland) 19:20240991 PubMed39091610

2024

SHP-1 mediates cigarette smoke extract-induced epithelial-mesenchymal transformation and inflammation in 16HBE cells.

Applications

Unspecified application

Species

Unspecified reactive species

Quan He,Shuanglan Xu,Xiaomei Ma,Yuanxia Qian,Xuzhi Lu,Weiqi Feng,Zi Chen

Scientific reports 14:5233 PubMed38433218

2024

circRNA_SLC8A1 promotes the survival of mycobacterium tuberculosis in macrophages by upregulating expression of autophagy-related protein SQSTM1/p62 to activate the NF-κB pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenyun Li,Yuan Gao,Bianfang Zhang,Wei Dong,Yuling Xi,Yan Li,Junwei Cui

International archives of allergy and immunology 184:471-480 PubMed36702106

2023

RBCK1 Overexpression Attenuates Inflammation and Mobility of Derp1-Induced Nasal Mucosal Cells by Downregulating NLRP3.

Applications

Unspecified application

Species

Unspecified reactive species

Jingwei Du,Lijuan Peng,Jun Feng,Tao Zhang

Frontiers in bioengineering and biotechnology 10:813070 PubMed35480984

2022

Downregulation of miR-760 Causes Human Intervertebral Disc Degeneration by Targeting the MyD88/Nuclear Factor-Kappa B Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xueliang Cui,Yanan Li,Junping Bao,Kun Wang,Xiaotao Wu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com